The size of adrenal incidentalomas correlates with insulin resistance. Is there a cause-effect relationship?

Clinical Endocrinology

Volumn 74, Issue 3, 2011, Pages 300-305

  Muscogiuri, Giovanna ^a   Sorice, Gian Pio ^a   Prioletta, Annamaria ^a   Mezza, Teresa ^a   Cipolla, Clelia ^a   Salomone, Enrica ^a   Giaccari, Andrea ^a,b   Pontecorvi, Alfredo ^a   Della Casa, Silvia ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CORTICOTROPIN; DEXAMETHASONE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROCORTISONE; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADRENAL INCIDENTALOMA; ADULT; AGED; ARTICLE; BODY FAT; CLAMP; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; CORTICOTROPIN BLOOD LEVEL; CUSHING SYNDROME; DIABETES MELLITUS; DISEASE SEVERITY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; HORMONE DETERMINATION; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE RELEASE; HYDROCORTISONE URINE LEVEL; INSULIN RESISTANCE; MALE; MEDICAL HISTORY; MORPHOLOGY; MULTIDETECTOR COMPUTED TOMOGRAPHY; ORAL GLUCOSE TOLERANCE TEST; PREVALENCE; PRIORITY JOURNAL; TRUNK; TUMOR GROWTH; TUMOR VOLUME;

EID: 79851498931     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2010.03928.x     Document Type: Article

References (34)

1. Chidiac, R.M., &, Aron, D.C., (1997) Incidentaloma. A disease of modern technology. Endocrinology and Metabolism Clinics of North America, 26, 233-253.
2. Griffing, G.T., (1994) Editorial: A-I-D-S: the new endocrine epidemic. The Journal of clinical endocrinology and metabolism, 79, 1530-1531.
3. Terzolo, M., Pia, A., AlÃ, A., Osella, G., et al. (2002) Adrenal incidentaloma: a new cause of the metabolic syndrome? Journal of Clinical Endocrinology and Metabolism, 87, 998-1003. (Pubitemid 36121054)
4. Garrapa, G., Pantanetti, P., Arnaldi, G., et al. (2001) Body composition and metabolic features in women with adrenal incidentaloma or Cushing's syndrome. Journal of Clinical Endocrinology and Metabolism, 86, 5301-5306. (Pubitemid 33070251)
5. Mantero, F., Terzolo, M., Arnaldi, G., et al. (2000) A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. Journal of Clinical Endocrinology and Metabolism, 85, 637-644.
6. Rossi, R., Tauchmanova, L., Luciano, A., et al. (2000) Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features. Journal of Clinical Endocrinology and Metabolism, 85, 1440-1448. (Pubitemid 32289484)
7. Terzolo, M., Alı', A., &, Osella, G., et al. (1998) Subclinical Cushing's syndrome in adrenal incidentaloma. Clinical endocrinology (Oxford), 48, 89-97. (Pubitemid 28122438)
8. Erbil, Y., AdemoÄlu, E., Ozbey, N., et al. (2006) Evaluation of the cardiovascular risk in patients with subclinical Cushing syndrome before and after surgery. World Journal of Surgery, 30, 1665-1671. (Pubitemid 44411221)
9. Ley, C.J., Lees, B., &, Stevenson, J.C., (1992) Sex- and menopause-associated changes in body-fat distribution. American Journal of Clinical Nutrition, 55, 950-954.
10. Chiodini, I., Morelli, V., Salcuni, A.S., et al. (2010) Beneficial metabolic effects of prompt surgical treatment in patients with an adrenal incidentaloma causing biochemical hypercortisolism. Journal of Clinical Endocrinology and Metabolism, 95, 2736-2745.
11. Tsagarakis, S., Vassiliadi, D., &, Thalassinos, N., (2006) Endogenous subclinical hypercortisolism: diagnostic uncertainties and clinical implications. Journal of Endocrinological Investigation, 29, 471-482. Review (Pubitemid 44043366)
12. Kratz, A., Ferraro, M., Sluss, P.M., et al. (2004) Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Laboratory reference values. New England Journal of Medicine, 351, 1548-1563.
13. NIH state-of-the-science statement on management of the clinically inapparent adrenal mass ("incidentaloma"). NIH consensus and state-of-the-science statements, 19, 1-25. Review.
14. Grumbach, M.M., Biller, B.M., Braunstein, G.D., et al. (2003) Management of the clinically inapparent adrenal mass ("incidentaloma"). Annals of Internal Medicine, 138, 424-429. (Pubitemid 36262654)
15. DeFronzo, R.A., Tobin, J.D., &, Andres, R., (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. American Journal of Physiology, 237, E214-E223. (Pubitemid 9249478)
16. Muscogiuri, G., Sorice, G.P., Prioletta, A., et al. (2010) 25-hydroxyvitamin D concentration correlates with insulin-sensitivity and BMI in obesity. Obesity (Silver Spring), 18, 1906-1910.
17. Yen, M.C., (1980) Sonography of the adrenal glands: normal glands and small masses. American Journal of Roentgenology, 135, 1167-1171.
18. Boscaro, M., Barzon, L., Fallo, F., et al. (2001) Cushing's syndrome. Lancet, 357, 783-791. (Pubitemid 32217692)
19. Arnaldi, G., Masini, A.M., Giacchetti, G., et al. (2000) Adrenal incidentaloma Brazilian. Journal of Medical and Biological Research, 33, 1177-1189.
20. Peppa, M., Boutati, E., Koliaki, C., et al. (2010) Insulin resistance and metabolic syndrome in patients with nonfunctioning adrenal incidentalomas: a cause-effect relationship? Metabolism, 59, 1435-1441.
21. Midorikawa, S., Sanada, H., Hashimoto, S., et al. (2001) The improvement of insulin resistance in patients with adrenal incidentaloma by surgical resection. Clinical Endocrinology, 54, 797-804. (Pubitemid 34208891)
22. Giaccari, A., Sorice, G., &, Muscogiuri, G., (2009) Glucose toxicity: the leading actor in the pathogenesis and clinical history of type 2 diabetes-mechanisms and potentials for treatment. Nutrition, metabolism, and cardiovascular diseases, 19, 365-377.
23. Ermetici, F., Malavazos, A.E., Corbetta, S., et al. (2007) Adipokine levels and cardiovascular risk in patients with adrenal incidentaloma. Metabolism, 56, 686-692. (Pubitemid 46574732)
24. Yilmaz, H., Tütüncü, N.B., &, Sahin, M., (2009) Two-year follow-up of thirty-two non-functional benign adrenal incidentalomas. Journal of Endocrinological Investigation, 32, 913-916.
25. Reincke, M., Fassnacht, M., Väth, S., et al. (1996) Adrenal incidentalomas: a manifestation of the metabolic syndrome? Endocrine Research, 22, 757-761. (Pubitemid 26424404)
26. Weber, M.M., Auernhammer, C.J., Kiess, W., et al. (1997) Insulin-like growth factor receptors in normal and tumorous adult human adrenocortical glands. European Journal of Endocrinology, 136, 296-303. (Pubitemid 27130054)
27. Kamio, T., Shigematsu, K., Kawai, K., et al. (1991) Immunoreactivity and receptor expression of insulinlike growth factor I and insulin in human adrenal tumors. An immunohistochemical study of 94 cases. American Journal of Pathology, 138, 83-91.
28. Bailyes, E.M., Navâe, B.T., Soos, M.A., et al. (1997) Insulin receptor/IGF-1 receptor hybrids are widely distributed in mammalian tissues: quantification of individual receptor species by selective immunoprecipitation and immunoblotting. Biochemical Journal, 327, 209-215. (Pubitemid 27455481)
29. Leung, K.C., Doyle, N., Ballesteros, M., et al. (2000) Insulin regulation of human hepatic growth hormone receptors: divergent effects on biosynthesis and surface translocation. Journal of Clinical Endocrinology and Metabolism, 85, 4712-4720. (Pubitemid 32157657)
30. Roberts, C.T.J., Brown, A.L., Graham, D.E., et al. (1986) Growth hormone regulates the abundance of insulin-like growth factor I RNA in adult rat liver. Journal of biological chemistry, 261, 10025-10028. (Pubitemid 17221930)
31. Snyder, D.K., &, Clemmons, D.R., (1990) Insulin-dependent regulation of insulin-like growth factor-binding protein-1. Journal of Clinical Endocrinology and Metabolism, 71, 1632-1636. (Pubitemid 120032786)
32. Clemmons, D.R., Snyder, D.K., &, Busby, W.H.J., (1991) Variables controlling the secretion of insulin-like growth factor binding protein-2 in normal human subjects. Journal of Clinical Endocrinology and Metabolism, 73, 727-733. (Pubitemid 21921930)
33. Gallagher, E.J., &, Leroith, D., (2010) The proliferating role of insulin and insulin-like growth factors in cancer. Trends in endocrinology and metabolism, 21, 610-618.
34. Johnson, J.A., &, Pollak, M., (2010) Insulin, glucose and the increased risk of cancer in patients with type 2 diabetes. Diabetologia, 53, 2086-2088.